Literature DB >> 26768559

Ebola clinical trials: Five lessons learned and a way forward.

Nathan M Thielman1, Coleen K Cunningham2, Christopher Woods2, Elizabeth Petzold2, Mark Sprenz3, James Russell4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26768559      PMCID： PMC5561545          DOI： 10.1177/1740774515619897

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  6 in total

1.  Adaptive clinical trials: a partial remedy for the therapeutic misconception?

Authors:  William J Meurer; Roger J Lewis; Donald A Berry
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

2.  Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.

Authors:  Bryan R Luce; Judith M Kramer; Steven N Goodman; Jason T Connor; Sean Tunis; Danielle Whicher; J Sanford Schwartz
Journal:  Ann Intern Med       Date:  2009-06-30       Impact factor: 25.391

3.  The platform trial: an efficient strategy for evaluating multiple treatments.

Authors:  Scott M Berry; Jason T Connor; Roger J Lewis
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

4.  Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015.

Authors:  Martin I Meltzer; Charisma Y Atkins; Scott Santibanez; Barbara Knust; Brett W Petersen; Elizabeth D Ervin; Stuart T Nichol; Inger K Damon; Michael L Washington
Journal:  MMWR Suppl       Date:  2014-09-26

5.  Evaluating clinical trial designs for investigational treatments of Ebola virus disease.

Authors:  Ben S Cooper; Maciej F Boni; Wirichada Pan-ngum; Nicholas P J Day; Peter W Horby; Piero Olliaro; Trudie Lang; Nicholas J White; Lisa J White; John Whitehead
Journal:  PLoS Med       Date:  2015-04-14       Impact factor: 11.069

6.  Randomised controlled trials for Ebola: practical and ethical issues.

Authors:  Clement Adebamowo; Oumou Bah-Sow; Fred Binka; Roberto Bruzzone; Arthur Caplan; Jean-François Delfraissy; David Heymann; Peter Horby; Pontiano Kaleebu; Jean-Jacques Muyembe Tamfum; Piero Olliaro; Peter Piot; Abdul Tejan-Cole; Oyewale Tomori; Aissatou Toure; Els Torreele; John Whitehead
Journal:  Lancet       Date:  2014-10-13       Impact factor: 79.321
  6 in total
  10 in total

1.  An Adaptive Information Borrowing Platform Design for Testing Drug Candidates of COVID-19.

Authors:  Liwen Su; Jingyi Zhang; Fangrong Yan
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-04-22       Impact factor: 2.585

2.  Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.

Authors:  Wei Shen Lim; Garry Meakin; Clare Brittain; Thomas Bewick; Lelia Duley
Journal:  Trials       Date:  2017-11-16       Impact factor: 2.279

3.  "You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.

Authors:  Nerina Vischer; Constanze Pfeiffer; Manuela Limacher; Christian Burri
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

Review 4.  Key data for outbreak evaluation: building on the Ebola experience.

Authors:  Anne Cori; Christl A Donnelly; Ilaria Dorigatti; Neil M Ferguson; Christophe Fraser; Tini Garske; Thibaut Jombart; Gemma Nedjati-Gilani; Pierre Nouvellet; Steven Riley; Maria D Van Kerkhove; Harriet L Mills; Isobel M Blake
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

5.  Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.

Authors:  Louise Sigfrid; Katherine Maskell; Peter G Bannister; Sharif A Ismail; Shelui Collinson; Sadie Regmi; Claire Blackmore; Eli Harriss; Kajsa-Stina Longuere; Nina Gobat; Peter Horby; Mike Clarke; Gail Carson
Journal:  BMC Med       Date:  2020-06-25       Impact factor: 8.775

6.  Research Ethics Committees (RECs) and epidemic response in low and middle income countries.

Authors:  Luchuo Engelbert Bain; Chia Gerald Ngwain; Julius Nwobegahay; Jeffery Gabriel Sumboh; Rogers Nditanchou; Paschal Kum Awah
Journal:  Pan Afr Med J       Date:  2018-11-28

Review 7.  Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better.

Authors:  Maya Hites; Jean-Louis Vincent
Journal:  Viruses       Date:  2022-06-29       Impact factor: 5.818

8.  Performance of different clinical trial designs to evaluate treatments during an epidemic.

Authors:  Matthias Brueckner; Andrew Titman; Thomas Jaki; Amanda Rojek; Peter Horby
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

9.  EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.

Authors:  Thomas Mooney; Elizabeth Smout; Bailah Leigh; Brian Greenwood; Luisa Enria; David Ishola; Daniela Manno; Mohamed Samai; Macaya Douoguih; Deborah Watson-Jones
Journal:  Clin Trials       Date:  2018-06-12       Impact factor: 2.486

10.  Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.

Authors:  Nigel Stallard; Lisa Hampson; Norbert Benda; Werner Brannath; Thomas Burnett; Tim Friede; Peter K Kimani; Franz Koenig; Johannes Krisam; Pavel Mozgunov; Martin Posch; James Wason; Gernot Wassmer; John Whitehead; S Faye Williamson; Sarah Zohar; Thomas Jaki
Journal:  Stat Biopharm Res       Date:  2020-07-29       Impact factor: 1.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.